|
1
|
Hudler P: Outlook on epigenetic
therapeutic approaches for treatment of gastric cancer. Current
Cancer Drug Targets. 18:65–88. 2018.PubMed/NCBI
|
|
2
|
Ondracek J, Fadrus P, Sana J, Besse A,
Loja T, Vecera M, Radova L, Smrcka M, Slampa P and Slaby O: Global
MicroRNA expression profiling identifies unique MicroRNA pattern of
radioresistant glioblastoma cells. Anticancer Res. 37:1099–1104.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wan X, Pu H, Huang W, Yang S, Zhang Y,
Kong Z, Yang Z, Zhao P, Li A, Li T and Li Y: Androgen-induced
miR-135a acts as a tumor suppressor through downregulating RBAK and
MMP11, and mediates resistance to androgen deprivation therapy.
Oncotarget. 7:51284–51300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu S, Gu Y, Huang Y, Wong TC, Ding H, Liu
T, Zhang Y and Zhang X: Novel biomarkers for non-functioning
invasive pituitary adenomas were identified by using analysis of
microRNAs expression profile. Biochem Genet. 55:253–267. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oze I, Shimada S, Nagasaki H, Akiyama Y,
Watanabe M, Yatabe Y, Matsuo K and Yuasa Y: Plasma microRNA-103,
microRNA-107, and microRNA-194 levels are not biomarkers for human
diffuse gastric cancer. J Cancer Res Clin Oncol. 143:551–554. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan M, Wang Z, Hu G, Yang Y, Lv W, Lu F
and Zhong H: A retrospective analysis of hyperthermic
intraperitoneal chemotherapy for gastric cancer with peritoneal
metastasis. Mol Clin Oncol. 5:395–399. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan X, Wang S, Liu M, Lu Z, Zhan Y, Wang
W and Xu AM: Histological and pathological assessment of miR-204
and SOX4 levels in gastric cancer patients. Biomed Res Int.
2017:68946752017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu N, Han Y, Liu H, Jiang M, Chu Y, Cao J,
Lin J, Liu Y, Xu B and Xie X: miR-5590-3p inhibited tumor growth in
gastric cancer by targeting DDX5/AKT/m-TOR pathway. Biochem Biophys
Res Commun. 503:1491–1497. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu M, Zhou X, Du Y, Huang Z, Zhu J, Xu J,
Cheng G, Shu Y, Liu P, Zhu W and Wang T: miR-20a induces cisplatin
resistance of a human gastric cancer cell line via targeting CYLD.
Mol Med Rep. 14:1742–1750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oh HK, Tan ALK, Das K, Ooi CH, Deng NT,
Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, et al: Genomic
loss of miR-486 regulates tumor progression and the OLFM4
antiapoptotic factor in gastric cancer. Clin Cancer Res.
17:2657–2667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW,
Choi SH, Lee JS and Cho JY: Overexpression of miR-196b and HOXA10
characterize a poor-prognosis gastric cancer subtype. World J
Gastroenterol. 19:7078–7088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim CH, Kim HK, Rettig RL, Kim J, Lee ET,
Aprelikova O, Choi IJ, Munroe DJ and Green JE: miRNA signature
associated with outcome of gastric cancer patients following
chemotherapy. BMC Med Genomics. 4:792011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Hou R, Niu X, Liu R, Wang Q, Wang C,
Li X, Hao Z, Yin G and Zhang K: Comparison of microarray and
RNA-Seq analysis of mRNA expression in dermal mesenchymal stem
cells. Biotechnol Lett. 38:33–41. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Meng F, Dai E, Yang F, Wang S,
Chen X, Yang L, Wang Y and Jiang W: Identification of associations
between small molecule drugs and miRNAs based on functional
similarity. Oncotarget. 7:38658–38669. 2016.PubMed/NCBI
|
|
17
|
Liu H, Zhang Q, Lou Q, Zhang X, Cui Y,
Wang P, Yang F, Wu F, Wang J, Fan T3 and Li S: Differential
analysis of lncRNA, miRNA and mRNA expression profiles and the
prognostic value of lncRNA in esophageal cancer. Pathol Oncol Res.
Apr 10–2019.(Epub ahead of print). View Article : Google Scholar
|
|
18
|
He S, Shi J, Mao J, Luo X, Liu W, Liu R
and Yang F: The expression of miR-375 in prostate cancer: A study
based on GEO, TCGA data and bioinformatics analysis. Pathol Res
Pract. 1523752019.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He K, Li W, Guan D, Gong M, Ye S, Fang Z,
Huang JF and Lu A: Regulatory network reconstruction of five
essential microRNAs for survival analysis in breast cancer by
integrating miRNA and mRNA expression datasets. Funct Integr
Genomics. Mar 12–2019.(Epub ahead of print). View Article : Google Scholar
|
|
20
|
Yu H, Ye L, Mansel RE, Zhang Y and Jiang
WG: Clinical implications of the influence of Ehm2 on the
aggressiveness of breast cancer cells through regulation of matrix
metalloproteinase-9 expressio. Mol Cancer Res. 8:1501–1512. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu R, Zhao G, Yang Y, Jiang Z, Cai J,
Zhang Z and Hu H: Long noncoding RNA HOTAIRM1 inhibits cell
progression by regulating miR-17-5p/PTEN axis in gastric cancer. J
Cell Biochem. 120:4952–4965. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Magalhães L, Quintana L, Lopes DCF, Vidal
AF, Pereira AL, D'Araujo Pinto LC, de Jesus Viana Pinheiro J,
Khayat AS, Goulart LR, Burbano R, et al: APC gene is modulated by
hsa-miR-135b-5p in both diffuse and intestinal gastric cancer
subtypes. BMC Cancer. 18:10552018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang
C, Huang D, Chen X, Zhang H, Zhuang R, et al: A five-microRNA
signature identified from genome-wide serum microRNA expression
profiling serves as a fingerprint for gastric cancer diagnosis. Eur
J Cancer. 47:784–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang H, Wang F, Chu D, Zhang W, Liao Z,
Fu Z, Yan X, Zhu H, Guo W, Zhang Y, et al: miR-93 functions as an
oncomiR for the downregulation of PDCD4 in gastric carcinoma. Sci
Rep. 6:237722016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P,
Nie Y, Wu K, Shi Y and Fan D: MiR-19a/b modulate the metastasis of
gastric cancer cells by targeting the tumour suppressor MXD1. Cell
Death Dis. 5:e11442014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Han T, Wei G and Wang Y:
Inhibition of microRNA-17/20a suppresses cell proliferation in
gastric cancer by modulating UBE2C expression. Oncol Rep.
33:2529–2536. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi J, Zhang Y, Jin N, Li Y, Wu S and Xu
L: MicroRNA-221-3p plays an oncogenic role in gastric carcinoma by
inhibiting PTEN expression. Oncol Res. 25:523–536. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu
W, Xiao S and Lu H: miR-21 plays a pivotal role in gastric cancer
pathogenesis and progression. Lab Invest. 88:1358–1366. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu H, Lin W and Tsai K: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shin VY and Chu K: MiRNA as potential
biomarkers and therapeutic targets for gastric cancer. World J
Gastroenterol. 20:10432–10439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tchernitsa OI, Kasajima A, Schäfer R,
Kuban RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W,
Ebert MP and Röcken C: Systematic evaluation of the miRNA-ome and
its downstream effects on mRNA expression identifies gastric cancer
progression. J Pathol. 222:310–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen X, Xie D, Wang L, Zhao Q, You Z and
Liu H: BNPMDA: Bipartite network projection for MiRNA-disease
association prediction. Bioinformatics. 34:3178–3186. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X, Niu Y, Wang G and Yan G: HAMDA:
Hybrid approach for MiRNA-disease association prediction. J Biomed
Inform. 76:50–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Su L, Liu X, Chai N, Lv L, Wang R, Li X,
Nie Y, Shi Y and Fan D: The transcription factor FOXO4 is
down-regulated and inhibits tumor proliferation and metastasis in
gastric cancer. BMC Cancer. 14:3782014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Matsuoka T and Yashiro M: The role of
PI3K/Akt/mTOR signaling in gastric carcinoma. Cancers (Basel).
6:1441–1463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu YJ, Wong BS, Yea SH, Lu CI and Weng SH:
Sinularin induces apoptosis through mitochondria dysfunction and
inactivation of the pI3K/Akt/mTOR pathway in gastric carcinoma
cells. Mar Drugs. 14(pii): E1422016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nadauld LD, Garcia S, Natsoulis G, Bell
JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, et al:
Metastatic tumor evolution and organoid modeling implicate TGFBR2
as a cancer driver in diffuse gastric cancer. Genome Biol.
15:4282014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu W, Yang Z and Lu N: Roles of PTEN
(Phosphatase and Tensin Homolog) in gastric cancer development and
progression. Asian Pac J Cancer Prev. 15:17–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
